Five thousand one hundred women age 18–50 years participated in a cervical cancer screening program using liquid-based cytology and human papillomavirus (HPV) DNA testing. Women with abnormal cytology testing, including atypical squamous cells of undetermined significance (ASCUS), or HPV DNA results positive for high-risk HPV types were referred for colposcopic examination. For this study, the liquid-based cytology was repeated at the time of colposcopy to determine the value of repeat screening. The cytology results of the initial screening for 5100 women found 3.3% with high-grade squamous intraepithelial lesions (HSIL), 4.3% with low-grade squamous intraepithelial lesions (LSIL), 9.7% ASCUS, 0.1% atypical glandular cells of unknown significance (AGUS), and 1.3% inadequate smear. Nineteen percent of patients tested positive for high-risk HPV types. In all, 870 women had abnormal cytology at the initial screening; 644 returned for colposcopy. Of 818 women who had negative Pap smear results but were positive for high-risk HPV, 433 returned for colposcopy. In addition, 245 women with normal cytology and negative HPV results agreed to undergo voluntary colposcopy and served as controls. In all, including 18 women with unsatisfactory or missing cytology and positive HPV results, 1340 women underwent colposcopic examination and 1333 had colposcopically directed biopsy. Women with negative or atypical histology, or women whose histologic specimen showed cervical intraepithelial neoplasia (CIN) 1, were referred back to their health clinics. Women who had CIN 2, 3, or adenocarcinoma-in-situ were advised to have the loop electrical excision procedure (LEEP) or cervical conization. Women in whom cancer was found were referred to a gynecologic oncologist for further care. Three cancers were identified in this study population; all were found in the initial screening smear. Among 153 women with HSIL cytology results at colposcopy, biopsy results showed CIN 2 or 3 in 104 (68%) and CIN 1 in 18 (12%). There were 30 women with HSIL cytology results at colposcopy who had negative or atypical histology results. Screening cytology was positive for HSIL in 9 of these patients, but there were 21 women whose initial cytology results and whose biopsy results were negative for high-grade disease. These women were advised to undergo excisional treatment for a high-grade lesion. They are the only patients for whom repeated cytology changed the course of clinical management. The results of the initial Pap smear and the smear taken at colposcopy were compared according to the interval of time between the 2. Among the 21 women with a discrepancy found between initial screening and repeat cytology, 9 were among 686 (1.31%) women who returned for colposcopy within 60 days of the initial screening, 8 were among 509 patients (1.57%) who had colposcopy 61 to 180 days after initial screening, and 4 were among 139 women (2.88%) with more than 180 days between initial screening and colposcopic examination (P for trend = 0.12, not significant).
Read full abstract